✦ LIBER ✦

A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation

✍ Scribed by Akerley, Wallace; Boucher, Kenneth; Rich, Nathan; Egbert, Lyle; Harker, Graydon; Bylund, Julie; Van Duren, Terry; Reddy, Chakravarthy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of erlotinib in combina

✍ Ciuleanu, T.; Tsai, C.-M.; Tsao, C.-J.; Milanowski, J.; Amoroso, D.; Heo, D.S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 718 KB

A randomised phase II study of pemetrexe

✍ Dittrich, Christian; Papai-Szekely, Zsolt; Vinolas, Nuria; Sederholm, Christer; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 517 KB

9149 Phase II study of bevacizumab in co

✍ Ferrer, N.; Cobo, M.; Paredes, A.; Méndez, M.; Muñoz-Langa, J.; Rueda, A.; de Mo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Phase II study of oral S-1 plus cisplati

✍ Kaira, Kyoichi; Tomizawa, Yoshio; Yoshino, Reiko; Miura, Yosuke; Yoshii, Akihiro 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 684 KB

First-line erlotinib and bevacizumab in

✍ Dingemans, A.- M. C.; de Langen, A. J.; van den Boogaart, V.; Marcus, J. T.; Bac 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 383 KB

476 Serum Proteomic Classification in Re

✍ Spigel, D.R.; Burris, H.A.; Greco, F.A.; Lipman, A.J.; Waterhouse, D.M.; Daniel, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 73 KB